MktsMarkets

Skye Bioscience, Inc.
NASDAQ: SKYEKey statistics
SKYE News
Stories mentioning SKYE from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 12,674 | 14,895 | 13,265 | 18,244 | 11,760 | 10,666 | 4,969 | 8,406 |
| Operating Income (Loss) | (12,674) | (14,895) | (13,265) | (18,244) | (11,760) | (10,666) | (4,969) | (8,406) |
| Interest Income | 170.00 | 314.00 | 418.00 | 533.00 | 619.00 | 732.00 | 908.00 | 961.00 |
| Interest Expense | ||||||||
| Other Expense | (2.00) | (42.00) | 0.00 | 0.00 | 41.00 | 0.00 | (1.00) | 0.00 |
| Pretax Income | (12,509) | (14,442) | (12,755) | (17,621) | (11,101) | (9,746) | (3,898) | (7,895) |
| Tax Provision | 0.00 | 0.00 | 0.00 | 3.00 | 2.00 | 0.00 | 0.00 | 8.00 |
| Net Income (Loss) | (12,509) | (14,442) | (12,755) | (17,625) | (11,103) | (9,746) | (3,898) | (7,903) |
| Earnings Per Share (Basic) | (0.32) | (0.36) | (0.32) | (0.44) | (0.28) | (0.27) | (0.10) | (0.20) |
| Earnings Per Share (Diluted) | (0.32) | (0.36) | (0.32) | (0.44) | (0.28) | (0.27) | (0.10) | (0.20) |
| Weighted Average Shares Outstanding (Basic) | 39,681 | 39,663 | 39,666 | 39,659 | 39,652 | 36,487 | 38,819 | 38,669 |
| Weighted Average Shares Outstanding (Diluted) | 39,681 | 39,663 | 39,666 | 39,659 | 39,652 | 36,487 | 38,819 | 38,669 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About SKYE
Skye Bioscience, Inc. (NASDAQ: SKYE) is a stock listed on the Nasdaq Stock Market under the ticker symbol SKYE. It last traded at $0.9800 (Nov 12, 2026, 1:05 PM ET), up 6.5% on the day. That gives Skye Bioscience a market capitalisation of $4.1M.
Over the past 52 weeks SKYE has traded between $0.5000 and $12.72.
For the quarter ended Mar 31, 2026 it reported a net loss of $12.5M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$12.5M |
| Dec 31, 2025 | — | -$14.4M |
| Sep 30, 2025 | — | -$12.8M |
| Jun 30, 2025 | — | -$17.6M |
From Skye Bioscience’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…